[Benign prostate hypertrophy and sexual health].
This article is centered on the possible impact of benign prostate hypertrophy on the male sexual life. Not only concerning the symptomatology of this affection but also concerning the side-effects of medication as well as, if necessary, a surgical intervention. A particular attention is given to the possibility of using new associations between medication, for instance between alpha-blockers and inhibitors of 5-phosphodiesterases.
Randone
Donato F
DF
Ospedale Gradenigo, Divisione di Urologia Corso Regina Margherita, 8 I-10153 Torino.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000601:surgery
D000317:Adrenergic alpha-Antagonists; D010726:Phosphodiesterase Inhibitors